A phase I trial of the safety, tolerance, and pharmacokinetics of oral ritonavir co-administered with lamivudine (3TC) and zidovudine (ZDV) [lamivudine/zidovudine] in HIV-1-infected pregnant women and their infants

Trial Profile

A phase I trial of the safety, tolerance, and pharmacokinetics of oral ritonavir co-administered with lamivudine (3TC) and zidovudine (ZDV) [lamivudine/zidovudine] in HIV-1-infected pregnant women and their infants

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Mar 2006

At a glance

  • Drugs Lamivudine/zidovudine (Primary) ; Ritonavir (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top